[1]
Farooq, A., Zulfiqar, B. and Asghar, K. 2022. Indoleamine 2,3- Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma. Journal of Cancer & Allied Specialties. 9, 1 (Sep. 2022). DOI:https://doi.org/10.37029/jcas.v9i1.501.